JP2001081466A5 - - Google Patents

Download PDF

Info

Publication number
JP2001081466A5
JP2001081466A5 JP2000229237A JP2000229237A JP2001081466A5 JP 2001081466 A5 JP2001081466 A5 JP 2001081466A5 JP 2000229237 A JP2000229237 A JP 2000229237A JP 2000229237 A JP2000229237 A JP 2000229237A JP 2001081466 A5 JP2001081466 A5 JP 2001081466A5
Authority
JP
Japan
Prior art keywords
group
diyl
unsubstituted
substituent
replaced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000229237A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001081466A (ja
Filing date
Publication date
Priority claimed from DE19934799A external-priority patent/DE19934799B4/de
Application filed filed Critical
Publication of JP2001081466A publication Critical patent/JP2001081466A/ja
Publication of JP2001081466A5 publication Critical patent/JP2001081466A5/ja
Pending legal-status Critical Current

Links

JP2000229237A 1999-07-28 2000-07-28 高いコントラスト値を有するアクティブマトリックスディスプレイ Pending JP2001081466A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19934799A DE19934799B4 (de) 1999-07-28 1999-07-28 Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten
DE19934799.9 1999-07-28

Publications (2)

Publication Number Publication Date
JP2001081466A JP2001081466A (ja) 2001-03-27
JP2001081466A5 true JP2001081466A5 (https=) 2007-09-13

Family

ID=7915941

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000229237A Pending JP2001081466A (ja) 1999-07-28 2000-07-28 高いコントラスト値を有するアクティブマトリックスディスプレイ

Country Status (3)

Country Link
US (1) US6482479B1 (https=)
JP (1) JP2001081466A (https=)
DE (1) DE19934799B4 (https=)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19825488A1 (de) * 1998-06-08 1999-12-09 Aventis Res & Tech Gmbh & Co Monostabiles ferroelektrisches Aktivmatrix-Display
DE19857352A1 (de) * 1998-12-11 2000-06-15 Clariant Gmbh Ferroelektrische Aktivmatrix-Displays mit weitem Arbeitstemperaturbereich
EP1367114A1 (en) * 2002-04-11 2003-12-03 Clariant International Ltd. Active matrix liquid crystal device and smectic liquid crystal mixture
US6824707B2 (en) 2001-10-23 2004-11-30 Clariant International Ltd. Active matrix liquid crystal device and smectic liquid crystal mixture
US20050119251A1 (en) * 2001-12-21 2005-06-02 Jian-Min Fu Nicotinamide derivatives and their use as therapeutic agents
US7582635B2 (en) 2002-12-24 2009-09-01 Purdue Pharma, L.P. Therapeutic agents useful for treating pain
CN1314999C (zh) * 2003-03-21 2007-05-09 Lg.菲利浦Lcd株式会社 采用双背光单元的双液晶显示装置
MX2007003332A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
BRPI0515482A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos e seus usos como agentes terapêuticos
AU2005286647A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
CN101084211A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为治疗剂的用途
BRPI0515500A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados piridazina para inibição de estearoil-coa-desaturase
MX2007003318A (es) 2004-09-20 2007-05-18 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
AU2005286728A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
EP1827438B2 (en) * 2004-09-20 2014-12-10 Xenon Pharmaceuticals Inc. Piperazin derivatives for inhibiting human stearoyl-coa-desaturase
WO2006045010A2 (en) 2004-10-20 2006-04-27 Resverlogix Corp. Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
CA2618646A1 (en) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
MX2007015675A (es) 2005-07-04 2008-02-20 Novo Nordisk As Antagonistas del receptor de histamina h3.
US8410109B2 (en) 2005-07-29 2013-04-02 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
JP4822432B2 (ja) * 2006-07-25 2011-11-24 日東電工株式会社 液晶パネル、及び液晶表示装置
JP2008102471A (ja) * 2006-09-21 2008-05-01 Nitto Denko Corp 液晶パネル、及び液晶表示装置
PT2118074E (pt) 2007-02-01 2014-03-20 Resverlogix Corp Compostos para a prevenção e tratamento de doenças cardiovasculares
CA2685266C (en) * 2007-04-27 2014-01-28 Purdue Pharma L.P. Trpv1 antagonists and uses thereof for the treatment of prevention of pain, ui and ulcer, ibd, or ibs in an animal
MX2009011601A (es) 2007-04-27 2009-11-10 Purdue Pharma Lp Agentes terapeuticos utiles para tratar el dolor.
SI2346837T1 (sl) 2008-06-26 2015-05-29 Resverlogix Corporation Postopki pripravljanja kinazolinonskih derivatov
US8759362B2 (en) 2008-10-24 2014-06-24 Purdue Pharma L.P. Bicycloheteroaryl compounds and their use as TRPV1 ligands
US8703962B2 (en) 2008-10-24 2014-04-22 Purdue Pharma L.P. Monocyclic compounds and their use as TRPV1 ligands
US8952021B2 (en) 2009-01-08 2015-02-10 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
KR101913109B1 (ko) 2009-03-18 2018-10-31 리스버로직스 코퍼레이션 신규한 소염제
US9757368B2 (en) 2009-04-22 2017-09-12 Resverlogix Corp. Anti-inflammatory agents
US8940716B2 (en) 2010-05-06 2015-01-27 Bristol-Myers Squibb Company Bicyclic heteroaryl compounds as GPR119 modulators
PE20141531A1 (es) 2011-06-22 2014-10-23 Purdue Pharma Lp Antagonistas de trpv1 que incluyen sustituyentes dihidroxi y sus usos
AU2012293417A1 (en) 2011-08-10 2013-05-02 Purdue Pharma L.P. TRPV1 antagonists including dihydroxy substituent and uses thereof
CN102645784B (zh) * 2011-10-21 2015-04-08 京东方科技集团股份有限公司 半透半反液晶显示面板及液晶显示器
CA2851996C (en) 2011-11-01 2020-01-07 Resverlogix Corp. Pharmaceutical compositions for substituted quinazolinones
CN103666482B (zh) * 2012-09-10 2016-05-25 苏州汉朗光电有限公司 一种近晶a相液晶材料
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
JP2016507496A (ja) 2012-12-21 2016-03-10 ゼニス・エピジェネティクス・コーポレイションZenith Epigenetics Corp. ブロモドメイン阻害剤としての新規複素環式化合物
US10111885B2 (en) 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
CN109097067B (zh) * 2017-06-20 2021-12-21 江苏和成显示科技有限公司 液晶组合物及其在液晶显示器件中应用
JP6979895B2 (ja) * 2018-02-05 2021-12-15 東ソー株式会社 チアゾール化合物及びその製造方法
KR20250133471A (ko) 2020-02-18 2025-09-05 길리애드 사이언시즈, 인코포레이티드 항바이러스 화합물
TWI775313B (zh) 2020-02-18 2022-08-21 美商基利科學股份有限公司 抗病毒化合物
TWI883391B (zh) 2020-02-18 2025-05-11 美商基利科學股份有限公司 抗病毒化合物
CA3216162A1 (en) 2021-04-16 2022-10-20 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides
AU2022328698B2 (en) 2021-08-18 2025-02-20 Gilead Sciences, Inc. Phospholipid compounds and methods of making and using the same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367924A (en) 1980-01-08 1983-01-11 Clark Noel A Chiral smectic C or H liquid crystal electro-optical device
EP0032362B1 (en) 1980-01-10 1984-08-22 Noel A. Clark Chiral smectic liquid crystal electro-optical device and process of making the same
DE3807862A1 (de) * 1988-03-10 1989-09-21 Merck Patent Gmbh Smektische fluessigkristallphase
JP2852544B2 (ja) * 1989-11-07 1999-02-03 チッソ株式会社 強誘電性液晶組成物
JP3132840B2 (ja) * 1991-03-22 2001-02-05 コニカ株式会社 感熱転写記録用受像シートおよび感熱転写記録方法
US6171519B1 (en) * 1995-07-17 2001-01-09 Hoechst Research & Technology Deutschland Gmbh & Co. Kg Ferroelectric liquid crystal mixture
JPH1025477A (ja) * 1996-07-09 1998-01-27 Mitsubishi Gas Chem Co Inc フェリ誘電性液晶組成物
DE19830203A1 (de) * 1998-07-07 2000-01-13 Aventis Res & Tech Gmbh & Co Monostabiles ferroelektrisches Aktivmatrix-Display
DE19857352A1 (de) * 1998-12-11 2000-06-15 Clariant Gmbh Ferroelektrische Aktivmatrix-Displays mit weitem Arbeitstemperaturbereich
JP4272733B2 (ja) * 1998-12-25 2009-06-03 キヤノン株式会社 液晶組成物
JP2000319658A (ja) * 1999-04-30 2000-11-21 Sony Corp 単安定強誘電液晶表示装置
DE19922723A1 (de) * 1999-05-18 2000-11-23 Clariant Gmbh Aktivmatrix-Displays mit hohem Kontrast
JP2000336361A (ja) * 1999-05-31 2000-12-05 Sony Corp 単安定強誘電液晶表示装置
DE19934798A1 (de) * 1999-07-28 2001-02-01 Clariant Gmbh Smektische Flüssigkristallschalt- oder Anzeigevorrichtung mit hohem Kontrast

Similar Documents

Publication Publication Date Title
JP2001081466A5 (https=)
JP3302356B2 (ja) チアゾール誘導体およびチアジアゾール誘導体を含有しそしてスメクテイツク液晶相を有するメジウム
CN112996883B (zh) 二苯并呋喃及二苯并噻吩衍生物
US5847149A (en) Thiadiazole derivatives, process for their preparation, and their use as precursors for the production of liquid crystals
US5759443A (en) Cyclopentyl derivatives
KR960006075B1 (ko) 액정 조성물
US5626791A (en) Aromatic compounds, and their use in liquid-crystalline mixtures
KR960000076B1 (ko) 키랄성 에스테르의 제조방법
US5104569A (en) Liquid crystalline mixtures including 2-phenylpyridine compounds
KR940005587A (ko) 액정 혼합물에 사용하기 위한 6원 환 함유 메타 치환된 방향족 화합물
CA2016632A1 (en) Cyclopropylalkyl or -alkenyl compounds, processes for their preparation, and their use in liquid-crystalline mixtures
JP2001123171A5 (https=)
JP2002532613A5 (https=)
JP4727180B2 (ja) フッ素化多環式化合物および液晶混合物におけるこれらの使用
JPH0931064A (ja) アルコキシアルコキシ−置換の含窒素複素環化合物誘導体
JPH03133938A (ja) アルキニル置換液晶成分、それらの製造方法及び液晶指示装置
EP0357702B1 (en) Fluorinated oligophenyl derivatives
KR920002525A (ko) 4-시아노-3-플루오로페닐에스테르
JP3157828B2 (ja) ピリジルピリミジン、その製造方法および液晶混合物におけるその使用
JP2856362B2 (ja) フルオロフェニルピリミジン化合物
JP2002517598A5 (https=)
Boeyens et al. Thermal oligomerisation of aryl isocyanides: formation of pyrazino [1, 2-a: 4, 5-a′] diindoles and indigo diarylimines
US6759101B2 (en) Liquid crystalline materials containing perfluoroalkyl and alkenyl tail groups
JP5019087B2 (ja) ポリ(オキシアルキレン)置換化合物
WO1990013611A3 (de) Optisch aktive verbindungen und flüssigkristalline phase